Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
604 | 3169 | 42.1 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
697 | 12289 | VISCERAL LEISHMANIASIS//CUTANEOUS LEISHMANIASIS//LEISHMANIASIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LEISHMANIA | Author keyword | 48 | 15% | 10% | 305 |
2 | LEISHMANIA MAJOR | Author keyword | 43 | 25% | 5% | 152 |
3 | LEISHMANIASIS | Author keyword | 31 | 13% | 7% | 229 |
4 | IMMUNOL TRAINING | Address | 29 | 72% | 1% | 23 |
5 | VISCERAL LEISHMANIASIS | Author keyword | 22 | 13% | 5% | 159 |
6 | SERV IMUNOL | Address | 14 | 25% | 2% | 48 |
7 | CUTANEOUS LEISHMANIASIS | Author keyword | 13 | 13% | 3% | 97 |
8 | EXPERIMENTAL LEISHMANIASIS | Author keyword | 13 | 69% | 0% | 11 |
9 | TRAINING SKIN DIS LEPROSY | Address | 11 | 25% | 1% | 39 |
10 | KINETOPLASTID MEMBRANE PROTEIN 11 | Author keyword | 11 | 100% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LEISHMANIA | 48 | 15% | 10% | 305 | Search LEISHMANIA | Search LEISHMANIA |
2 | LEISHMANIA MAJOR | 43 | 25% | 5% | 152 | Search LEISHMANIA+MAJOR | Search LEISHMANIA+MAJOR |
3 | LEISHMANIASIS | 31 | 13% | 7% | 229 | Search LEISHMANIASIS | Search LEISHMANIASIS |
4 | VISCERAL LEISHMANIASIS | 22 | 13% | 5% | 159 | Search VISCERAL+LEISHMANIASIS | Search VISCERAL+LEISHMANIASIS |
5 | CUTANEOUS LEISHMANIASIS | 13 | 13% | 3% | 97 | Search CUTANEOUS+LEISHMANIASIS | Search CUTANEOUS+LEISHMANIASIS |
6 | EXPERIMENTAL LEISHMANIASIS | 13 | 69% | 0% | 11 | Search EXPERIMENTAL+LEISHMANIASIS | Search EXPERIMENTAL+LEISHMANIASIS |
7 | KINETOPLASTID MEMBRANE PROTEIN 11 | 11 | 100% | 0% | 6 | Search KINETOPLASTID+MEMBRANE+PROTEIN+11 | Search KINETOPLASTID+MEMBRANE+PROTEIN+11 |
8 | LEISHMANIA MAJOR INFECTION | 9 | 83% | 0% | 5 | Search LEISHMANIA+MAJOR+INFECTION | Search LEISHMANIA+MAJOR+INFECTION |
9 | HUMAN CUTANEOUS LEISHMANIASIS | 9 | 67% | 0% | 8 | Search HUMAN+CUTANEOUS+LEISHMANIASIS | Search HUMAN+CUTANEOUS+LEISHMANIASIS |
10 | LEISHMANIA DONOVANI | 9 | 12% | 2% | 70 | Search LEISHMANIA+DONOVANI | Search LEISHMANIA+DONOVANI |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MAJOR INFECTION | 401 | 74% | 9% | 296 |
2 | CUTANEOUS LEISHMANIASIS | 265 | 27% | 26% | 827 |
3 | EXPERIMENTAL VISCERAL LEISHMANIASIS | 217 | 60% | 7% | 236 |
4 | MURINE LEISHMANIASIS | 178 | 54% | 7% | 232 |
5 | MURINE CUTANEOUS LEISHMANIASIS | 158 | 74% | 4% | 116 |
6 | SUSCEPTIBLE BALB C MICE | 125 | 75% | 3% | 90 |
7 | DONOVANI INFECTION | 103 | 60% | 4% | 113 |
8 | EXPERIMENTAL CUTANEOUS LEISHMANIASIS | 98 | 71% | 3% | 80 |
9 | DONOVANI INFECTIONS | 82 | 86% | 1% | 42 |
10 | MUCOSAL LEISHMANIASIS | 79 | 47% | 4% | 125 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The immunology of susceptibility and resistance to Leishmania major in mice | 2002 | 601 | 130 | 82% |
Leishmaniasis: complexity at the host-pathogen interface | 2011 | 146 | 110 | 45% |
CD8(+) T cells in cutaneous leishmaniasis: the good, the bad, and the ugly | 2015 | 1 | 73 | 84% |
Vaccines for visceral leishmaniasis: A review | 2015 | 1 | 89 | 57% |
Second-generation vaccines against leishmaniasis | 2005 | 130 | 54 | 85% |
THE REGULATION OF IMMUNITY TO LEISHMANIA-MAJOR | 1995 | 946 | 155 | 49% |
Interleukin-10 and the pathogenesis of human visceral leishmaniasis | 2007 | 120 | 88 | 63% |
Leishmania vaccines: progress and problems | 2006 | 88 | 216 | 73% |
T helper (h)1/Th2 and Leishmania: paradox rather than paradigm | 2005 | 114 | 76 | 80% |
Immunopathogenesis of infection with the visceralizing Leishmania species | 2005 | 127 | 140 | 68% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOL TRAINING | 29 | 72% | 0.7% | 23 |
2 | SERV IMUNOL | 14 | 25% | 1.5% | 48 |
3 | TRAINING SKIN DIS LEPROSY | 11 | 25% | 1.2% | 39 |
4 | WHO IMMUNOL TRAINING | 10 | 52% | 0.4% | 14 |
5 | HOSP UNIV PROF EDGARD SANTOS | 9 | 23% | 1.1% | 36 |
6 | PARASITE VACCINES DEV | 9 | 67% | 0.3% | 8 |
7 | DISCIPLINE PATHOL TRANSMISSIBLE DIS | 8 | 70% | 0.2% | 7 |
8 | WHO IRTC | 6 | 71% | 0.2% | 5 |
9 | PESQUISAS GONCALO MONIZ | 6 | 11% | 1.5% | 48 |
10 | MOL IMMUNOL VACCINE | 6 | 28% | 0.5% | 17 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000179533 | LIPOPHOSPHOGLYCAN//LEISHMANIA//GP63 |
2 | 0.0000148149 | VISCERAL LEISHMANIASIS//CUTANEOUS LEISHMANIASIS//LEISHMANIASIS |
3 | 0.0000127964 | CANINE VISCERAL LEISHMANIASIS//LEISHMANIA INFANTUM//CANINE LEISHMANIASIS |
4 | 0.0000113289 | HEPATOPROTECTIVE PROPERTY//ACALYPHA RACEMOSA//ANTIOXIDANT TRACE ELEMENTS |
5 | 0.0000064034 | CANCER BIOTHERAPY//IST TIPIZZAZ TISSUTALE PROBLEMI DIALISI//INTRACELLULAR IMMUNOFLUORESCENCE |
6 | 0.0000049917 | NITROPHORIN//SECT MED ENTOMOL//VECTOR MOL BIOL SECT |
7 | 0.0000043857 | METACASPASE//DYSKINETOPLASTIDY//APOPTOSIS LIKE PROGRAMMED CELL DEATH |
8 | 0.0000042775 | ESTUDIOS TRIPANOSOMIASIS//CHINESE LIVER FLUKE//HIS 62 |
9 | 0.0000038337 | INTERLEUKIN 12//IL 12//IL 12 RECEPTOR |
10 | 0.0000036406 | SLC11A1//NRAMP1//MCGILL STUDY HOST ISTANCE |